We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Booting in

7 February 2006

The UK regulator has decided not to refer the chemist s merger with Alliance Unichem for a lengthy competition enquiry. That raises the bar for private equity groups plotting a counterbid. They will have to offer a big premium to stop the deal going ahead.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)